🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the safety, pharmacokinetics, pharmacodynamics and cli...
Status
Completed
Location
UCLA Oncology Center
Start Date
2015-06
Trial ID
NCT02481154
Treatments Being Tested
Vorasidenib in combination with pembrolizumab in participants with recurren...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-01-20
Trial ID
NCT05484622
Treatments Being Tested
Study AG881-C-004 is a phase 3, multicenter, randomized, double-blind, plac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-01-05
Trial ID
NCT04164901
Treatments Being Tested
The purpose of this Phase I, open-label study is to evaluate the absorption...
Status
Completed
Location
Covance Clinical Research Unit Inc.
Start Date
2019-05-16
Trial ID
NCT03960502
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics (PK) and safet...
Status
Completed
Location
WCCT GLobal
Start Date
2019-10-02
Trial ID
NCT04145128
Treatments Being Tested
This is an open-label, multi-center Phase 1 study of LY3410738, an oral, co...
Status
Active Not Recruiting
Location
City of Hope National Medical Center
Start Date
2020-11-19
Trial ID
NCT04603001
Treatments Being Tested
The main purpose of this study is to examine the effect of multiple doses o...
Status
Completed
Location
Celerion, Inc
Start Date
2019-07-15
Trial ID
NCT04015687
Treatments Being Tested
The purpose of this study is to compare the single-dose pharmacokinetics (P...
Status
Completed
Location
Celerion
Start Date
2019-09-30
Trial ID
NCT04128787
Treatments Being Tested
The purpose of this Phase I, multicenter study is to evaluate the safety, p...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-07
Trial ID
NCT02492737
Treatments Being Tested
The objective of this study is to determine the efficacy, safety, and pharm...
Status
Active Not Recruiting
Location
The Second People's Hospital of Shenzhen
Start Date
2024-10-18
Trial ID
NCT06780930
Treatments Being Tested